NAME Adroit-Medical Litigation Resource, Inc. – Trademark Portfolio

Entity Type: 03

NAME Adroit-Medical Litigation Resource, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 45 (Legal & Security Services) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ADROIT. The owner is based in Monroe, NC.

2118 Genseis Dr.

Monroe, NC 28110

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ADROIT
ADROIT
Registered 2018

Trademark Classifications

NAME Adroit-Medical Litigation Resource, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does NAME Adroit-Medical Litigation Resource, Inc. have?

NAME Adroit-Medical Litigation Resource, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does NAME Adroit-Medical Litigation Resource, Inc. file in?

NAME Adroit-Medical Litigation Resource, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 45 (Legal & Security Services). Class 45 covers legal services; security services for the protection of property and individuals.

What are NAME Adroit-Medical Litigation Resource, Inc.'s most well-known trademarks?

NAME Adroit-Medical Litigation Resource, Inc.'s registered trademark portfolio includes well-known marks such as ADROIT. These are among 1 currently registered trademark in the portfolio.

What is NAME Adroit-Medical Litigation Resource, Inc.'s trademark registration success rate?

NAME Adroit-Medical Litigation Resource, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.